Table 2.
Relative effects and its 95% credible interval of all pairwise panels for sensitivity based on Bayesian network meta-analysis method.
| A | B | C | D | E | H | I | K | M | |
|---|---|---|---|---|---|---|---|---|---|
| A | 1 | ||||||||
| B | 15.55 (1.8-159.59) | 1 | |||||||
| C | 9.88 (1.09-93.44) | 0.63 (0.24-1.56) | 1 | ||||||
| D | 7.87 (0.88-77.78) | 0.51 (0.18-1.33) | 0.8 (0.29-2.11) | 1 | |||||
| E | 14.87 (1.65-154.2) | 0.96 (0.35-2.56) | 1.52 (0.59-4.03) | 1.89 (0.69-5.49) | 1 | ||||
| H | 4.81 (0.32-77.45) | 0.31 (0.05-2.11) | 0.49 (0.07-3.3) | 0.61 (0.09-4.61) | 0.32 (0.05-2.3) | 1 | |||
| I | 5.78 (0.38-96.46) | 0.36 (0.05-2.74) | 0.58 (0.09-4.18) | 0.72 (0.1-5.68) | 0.38 (0.05-2.82) | 1.19 (0.09-15.06) | 1 | ||
| K | 2.53 (0.15-44.93) | 0.16 (0.02-1.2) | 0.25 (0.03-1.89) | 0.32 (0.04-2.5) | 0.17 (0.02-1.34) | 0.52 (0.04-7.33) | 0.44 (0.03-5.73) | 1 | |
| M | 11.61 (1.49-102.5) | 0.74 (0.34-1.58) | 1.17 (0.57-2.44) | 1.46 (0.61-3.61) | 0.77 (0.33-1.82) | 2.39 (0.4-14.24) | 2.01 (0.33-12.07) | 4.59 (0.7-30.51) | 1 |
A: MMP-9/TIMP-1; B: M-CSF+CA15; C: VEGF + CA 15-3; D: VEGF + M-CSF + CA 15-3; E: VEGF+ M-CSF; H: CA 15.3 + IL-18; I: MSA + B2m; K: TF1+TF2+TF3; M: mammography.